Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,300
Closed -$367K 285
2025
Q3
$367K Hold
1,300
0.06% 188
2025
Q2
$363K Hold
1,300
0.06% 191
2025
Q1
$405K Hold
1,300
0.07% 177
2024
Q4
$339K Hold
1,300
0.06% 204
2024
Q3
$419K Buy
+1,300
New +$425K 0.07% 180

Other funds holding AMGN

Insight Advisors's AMGN Position: Q1 2026 in Review

Insight Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,880 shares worth $661K. The position accounts for 0.13% of the portfolio, ranked #109.

Insight Advisors first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $703K in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Insight Advisors held 1,880 shares of Amgen worth $661K as of Q1 2026.
  • Insight Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.13% of Insight Advisors's portfolio in Q1 2026, its #109 holding.
  • Insight Advisors first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Insight Advisors's Amgen position peaked at $703K in Q4 2022.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.